TRIM21-mediated ubiquitination and phosphorylation of ERK1/2 promotes cell proliferation and drug resistance in pituitary adenomas. Liu Y, Liu F, Li C, Zhang T, et al. Neuro Oncol 2025;27:727-742.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Y, Liu F, Li C, Zhang T, et al. TRIM21-mediated ubiquitination and phosphorylation of ERK1/2 promotes cell proliferation and drug resistance in pituitary adenomas. Neuro Oncol 2025;27:727-742.
PMID: 39533840